医学
三阴性乳腺癌
乳腺癌
转移性乳腺癌
三重阴性
结合
抗体-药物偶联物
肿瘤科
抗体
癌症
内科学
单克隆抗体
免疫学
数学
数学分析
标识
DOI:10.1016/s1470-2045(19)30074-9
摘要
Results of a recent trial have shown durable objective responses in patients with heavily pretreated, metastatic, triple-negative breast cancer who were treated with the antibody-drug conjugate sacituzumab govitecan-hziy.
科研通智能强力驱动
Strongly Powered by AbleSci AI